Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 790
Clinical Pharmacology & Biopharmaceutics received 790 citations as per Google Scholar report
Clinical Pharmacology & Biopharmaceutics peer review process verified at publons
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Genamics JournalSeek
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Paraskevi F Katsakiori
Department of Pharmacology
School of Medicine
University of Patras
Greece
Biography
Dr. Paraskevi F. Katsakiori finished her studies towards a Medical Degree from the School of Medicine, University of Patras in 2000. She, then, pursued postgraduate studies in Basic Medical Sciences in the same Institution, where she got her M.Sc degree in 2003. She finished her PhD studies in the field of Pharmacology-Toxicology in June 2010. She holds the medical practice professional license since 2000 and the family practice license since 2007. She has participated in more than 40 presentations in national and international scientific conferences and authored or co-authored more than 15 peer review journal papers and 8 medical book chapters. The last four years, she actively acts as a referee in various scientific journals.
Research Interest
Epidemiologic, Pharmacogenomic and Pharmacokinetic studies.
Certificate
Global Speakers in the subject
Global Experts in the subject
Publications
Personalized Medicine: A Reality or A Dream?
| Paraskevi F Katsakiori |
| Editorial: Clin Pharmacol Biopharm 2012, 1:e101 |
| DOI: 10.4172/2167-065X.1000e101 |
